Do Vaccines Need a Gender Perspective? Influenza Says Yes!
Open Access
- 5 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 715688
Abstract
Background: Sex differences in immune responses are well known. However, the humoral response in males and females in the case of influenza vaccination is yet to be characterized since studies have shown uneven results.Methods: A retrospective study was conducted in 2,243 individuals (46.9% males) divided by age (15–64 and ≥65 years old). A serological analysis was performed by hemagglutination inhibition assay (HI) just before and 28 days after annual vaccination against seasonal influenza viruses in people vaccinated during the 2006–2018 seasons. A comparison of the humoral responses against influenza A and B viruses contained in the vaccine, between male and female individuals in young adults and elderly was conducted.Results: Significative higher humoral response against classical influenza A (H1N1), A(H1N1)pdm09 subtype and B/Victoria lineage in terms of seroconversion rate were found in elderly women. No significant differences were found in the case of A(H3N2) subtype.Conclusions: Elderly women seem to display a greater humoral response against classical A(H1N1), pandemic A(H1N1)pmd09 and B/Victoria lineage than elderly men. Sex dimorphism does not affect young adults.Keywords
Funding Information
- Junta de Castilla y León
This publication has 32 references indexed in Scilit:
- Mechanisms of sex disparities in influenza pathogenesisJournal of Leukocyte Biology, 2012
- Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 miceVaccine, 2011
- Sex- and Age-Related Differences in Morbidity Rates of 2009 Pandemic Influenza A H1N1 Virus of Swine Origin in JapanPLOS ONE, 2011
- Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasonsBMC Infectious Diseases, 2010
- Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenzaCanadian Medical Association Journal, 2010
- Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaJAMA, 2009
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005)Archives of internal medicine (1960), 2008
- Sexual dimorphism of humoral immunity with human vaccinesVaccine, 2008
- Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsVaccine, 2007